August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Jun Gong: Dr. Cigliola PhII SURE trial of neoadj sacituzumab govitecan for cis-ineligible MIBC
Jun 5, 2024, 09:58

Jun Gong: Dr. Cigliola PhII SURE trial of neoadj sacituzumab govitecan for cis-ineligible MIBC

Jun Gong, Medical Oncologist and Researcher in Gastrointestinal and Genitourinary cancers at Cedars-Sinai, shared a post on X:

Dr. Cigliola PhII SURE trial of neoadj sacituzumab govitecan for cis-ineligible MIBC

18/21 patients finished all 4C 47.6% pCR rate but 3 deaths (1 treatment-related) after 1C, required amendment to lower dose and require GCSF, several patients with cCR.

Jun Gong

Source: Jun Gong/X